From: Controversies in bipolar disorder; role of second-generation antipsychotic for maintenance therapy
Antipsychotic | Polaritya | Receptor profile in order of affinityb | Common side effectsb |
---|---|---|---|
Aripiprazole | Mania, mixed features | D2 partial agonist 5HT2A antagonist 5HT1A partial agonist 5HT7 antagonist 5HT2C partial agonist α2 antagonist | Akathisia, headache, nausea |
Asenapine | Mania/mixed features, depression | 5HT2c antagonist 5HT2a antagonist 5HT7 antagonist 5HT2b antagonist 5HT6 antagonist 5HT7 α2B antagonist D3 antagonist H1 antagonist α1 antagonist α2A antagonist α2C antagonist D2 antagonist D1 antagonist 5 HT5a antagonist 5 HT1a partial agonist H2 antagonist α1 antagonist | Sedation, EPSEs, postural hypotension |
Cariprazine | Mania/mixed features | D3 partial agonist D2 partial agonist 5HT2B antagonist 5HT1A partial agonist 5HT2A antagonist H1 antagonist 5HT7 antagonist 5HT2C antagonist α 1A antagonist | Akathisia, EPSEs, nausea |
Lurasidone | Mania/mixed features, depression | 5HT7 antagonist D2 antagonist 5HT2Aantagonist 5HT1Aantagonist α2 antagonist | EPSEs, sedation |
Olanzapine | Mania/mixed features, depressionc | H1 antagonist 5HT2A antagonist 5HT2C inverse agonist D2 antagonist M1-M5 antagonist | Sedation, weight gain, dyslipidaemia |
Quetiapine | Mania/mixed features, depression | H1 antagonist α1A antagonist α2C antagonist α1B antagonist α2B antagonist 5HT2A antagonist D2 antagonist 5HT7 antagonist Norquetiapine (metabolite of quetiapine) H1 antagonist 5HT2B antagonist M3 antagonist M5 antagonist M1 antagonist 5HT1A partial agonist 5HT2A antagonist NET inhibitor α1 antagonist D2 antagonist (higher doses) | Sedation, weight gain, postural hypotension |
Risperidone | Mania | 5HT2A inverse agonist D2 antagonist 5HT7 antagonist α1 antagonist 5HT2C inverse agonist H1 antagonist α2 antagonist | EPSEs, weight gain, elevated prolactin, postural hypotension |